Sardana Vandit, Burzynski Joanna, Hasan Khaled, Zalzal Paul
Division of Orthopedic Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada.
Department of Rehabilitation Sciences, McMaster University, Hamilton, Ontario, Canada.
J Orthop. 2018 Aug 16;15(3):812-816. doi: 10.1016/j.jor.2018.08.022. eCollection 2018 Sep.
Given the potential side effect profile of steroids, the need for an alternative injectable anti-inflammatory is needed. The purpose of this systematic review was to compare corticosteroid injections with non-steroidal anti-inflammatory drug (NSAID) injections for musculoskeletal pain.
Reviewers with methodological and content expertise searched three databases: PUBMED, Medline and EMBASE. Two blinded reviewers searched, screened, and evaluated the data quality. Data was abstracted in duplicate. Agreement and descriptive statistics are presented.
Four studies were included. All four studies found no statistically significant differences in improvements on the visual analog scale. The follow-up period within the four studies ranged between 2 weeks and 3 months. No statistically significant differences were demonstrated between the two groups with regards to functional outcomes.
The studies reviewed, while limited in quantity, show that compared with corticosteroids, NSAIDs provide equivalent, if not better, pain relief from the musculoskeletal ailments assessed. Further, there is weak evidence supporting a lower recurrence rate of symptoms with NSAIDs when compared to corticosteroids. There is a need for more long-term high-quality studies on this topic.
Level II (Systematic review of Level II and III studies).
鉴于类固醇可能存在的副作用,需要一种替代性的注射用抗炎药物。本系统评价的目的是比较皮质类固醇注射剂与非甾体抗炎药(NSAID)注射剂治疗肌肉骨骼疼痛的效果。
具有方法学和内容专业知识的 reviewers 检索了三个数据库:PUBMED、Medline 和 EMBASE。两名盲法 reviewers 进行检索、筛选并评估数据质量。数据进行了重复提取。呈现了一致性和描述性统计结果。
纳入了四项研究。所有四项研究均发现,视觉模拟量表的改善情况无统计学显著差异。四项研究中的随访期为 2 周 至 3 个月。两组在功能结局方面未显示出统计学显著差异。
所审查的研究虽然数量有限,但表明与皮质类固醇相比,NSAIDs 从所评估的肌肉骨骼疾病中提供了同等甚至更好的疼痛缓解效果。此外,有微弱证据支持与皮质类固醇相比,NSAIDs 的症状复发率更低。需要针对该主题开展更多长期高质量研究。
二级(对二级和三级研究的系统评价)。